Success Metrics

Clinical Success Rate

95.5%

Based on 21 completed trials

Completion Rate

95%(21/22)

Active Trials

1(4%)

Results Posted

5%(1 trials)

Terminated

1(4%)

Phase Distribution

Ph phase_2

Ph phase_3

Ph phase_4

Ph early_phase_1

Ph not_applicable

79%

Ph phase_1

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution28 total trials

Early Phase 1First-in-human

1(3.6%)

Phase 1Safety & dosage

1(3.6%)

Phase 2Efficacy & side effects

2(7.1%)

Phase 3Large-scale testing

1(3.6%)

Phase 4Post-market surveillance

1(3.6%)

N/ANon-phased studies

22(78.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

95.5%

21 of 22 finished

Non-Completion Rate

4.5%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(21)

Terminated(1)

Other(5)

Detailed Status

Completed21

unknown5

Terminated1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

95.5%

Most Advanced

Phase 4

Trials by Phase

Early Phase 11 (3.6%)

Phase 11 (3.6%)

Phase 22 (7.1%)

Phase 31 (3.6%)

Phase 41 (3.6%)

N/A22 (78.6%)

Trials by Status

unknown518%

terminated14%

completed2175%

recruiting14%

Recent Activity

1 active trials

Showing 5 of 28

recruitingnot_applicable

The Mitopure Challenge to Detect Levels of Urolithin A in Dried Blood Spots

NCT04985630

completednot_applicable

Impact of Antioxidant Juice Intake on Brain Injury and Placental Pathology in Infants With Intrauterine Growth Restriction (IUGR)

NCT04394910

completednot_applicable

Clinical Trials (28)

Showing 20 of 28 trialsScroll for more

NCT04985630Not Applicable

The Mitopure Challenge to Detect Levels of Urolithin A in Dried Blood Spots

Recruiting

NCT04394910Not Applicable

Impact of Antioxidant Juice Intake on Brain Injury and Placental Pathology in Infants With Intrauterine Growth Restriction (IUGR)

Completed

NCT04596254Not Applicable

Detection of Gut Metabolites in Mother's Milk Following Juice Intake

Completed

NCT05861544Not Applicable

NUTRItion-driven Detoxification of OPioid Addicted patiEnts

Unknown

NCT00060086Not Applicable

Pomegranate Juice in Treating Patients With Recurrent Prostate Cancer

Completed

NCT03496584Not Applicable

Effects of Phytonutrients on Vascular Health and Skin in Obese Males

Terminated

NCT04341961Not Applicable

Effect of Pomegranate Juice Consumption on the Health of Mothers and Infants During Breastfeeding

Completed

NCT04160312Not Applicable

Mitopure™ (Proprietary Urolithin A) Bioavailability in Healthy Adults

Completed

NCT02093130Phase 2

Study of Pomegranate Juice on Memory in Older Adults

Completed

NCT02605850Not Applicable

Effects of Phytonutrients on Vascular Health

Completed

NCT03713164Not Applicable

The Effects of Ellagic Acid From Pomegranate Juice vs. Pure Ellagic Acid on Healthy Male Subjects

Completed

NCT02233478Not Applicable

Comparing the Effect of Whey and Soy Protein on the Absorption of Pomegranate Polyphenols in the Human Body

Completed

NCT03978013Not Applicable

Pomegranate Juice Effect on Oxidative Stress in Infertile Women During IVF Treatment

Unknown

NCT03258346Not Applicable

Reversing Muscle Loss With Exercise Training and Daily Consumption of Pomegranate Juice

Completed

NCT03318042Not Applicable

Genotype, Metabotype and Diet in a Cohort of Children and Adolescents From the Southeast of Spain.

Completed

NCT02258776Not Applicable

The Effect of Pomegranate on Aging and Inflammation of the Skin

Completed

NCT02559843Phase 4

Effects of Pomegranate Juice on Oxidative Stress in Patients With type2 Diabetes

Completed

NCT00668954Not Applicable

Antioxidant Effects of Pomegranate Juice Versus Placebo in Adults With Type 2 Diabetes Mellitus

Completed

NCT01562340Not Applicable

Pomegranate and Hemodialysis Pilot Trial

Completed

NCT02298621Not Applicable

Pomegranate Juice and Metabolic Syndrome

Completed

Drug Details

Intervention Type: DIETARY SUPPLEMENT
Total Trials: 28